Cresco Labs Inc. (CRLBF) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.02 per share a year ago. These figures ...
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Cresco Labs Inc. (CRLBF) is a stock that can certainly grab the attention of many ...
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands ...
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most ...
Cresco Labs Inc.'s share price is not expected to significantly increase due to uncertainty in the US cannabis industry and lack of federal legislation and changes to rules and regulations. The ...
The market expects Cresco Labs Inc. (CRLBF) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2022. This widely-known consensus ...
Cresco Labs Inc. reported an ugly Q1 2023 with revenues falling 10% YoY. This MSO is likely to languish due to the Columbia Care merger struggling to complete divestitures needed for regulatory ...
Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of ...
Visit a quote page and your recently viewed tickers will be displayed here. Marc Lustig founded Cannabis Royalties & Holdings Corp. in 2016, where he worked as Chief Executive Officer & Director from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results